Search - tctmd.com

Displaying 501 - 520 of 609

Sort: Relevancy | Date

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Caitlin E. Cox

June 14, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

Presentation EuroPCR 2017

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Presenter: Ted E. Feldman

May 16, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Daily News

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Yael L. Maxwell

April 18, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Presentation ECHO 2017

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement

Presenter: Florian Deuschl

March 31, 2017

News Conference News ACC 2017

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

Michael O'Riordan

March 24, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

Presentation SIF 2017

Novel Applications: Utilizing Impella to Support TAVR Patients

Presenter: Robert D. Riley

March 11, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

News Daily News

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Shelley Wood

February 23, 2017

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Todd Neale

February 06, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

Presentation Miami Valves 2017

Progress in Novel Polymer Aortic Valve

Presenter: Amit N. Patel

January 29, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Todd Neale

January 06, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Advertisement

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

LivaNova Acquires Caisson Interventional, LLC

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

Live From Washington: ACC 2017, Day One

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Novel Applications: Utilizing Impella to Support TAVR Patients

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Progress in Novel Polymer Aortic Valve

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content